Aim 1: Identify synergistic combinations of Dox and paclitaxel in vitro. Aim 2: To fabricate and characterize polymeric depots containing doxorubicin and paclitaxel Aim 3: To evaluate synergistic cytotoxic effect of released Dox and paclitaxel against human hepatocellular carcinoma (Hep G2)